Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept Phase IIB in Active Rheumatoid Arthritis on Methotrexate
NCT00162266Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2000
- Primary completion
- Sep 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 11
01
Overview
Phase 2, randomised, double-blind trial of abatacept in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Primary endpoint: American College of Rheumatology 20% Improvement Criteria at Day 180. Started Oct 2000; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00162266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00162266.